Macroaxis: Personalized Investing  
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
 US Market Closed: Feb 8, 03:44 AM 2012 
  NYSE  8069.71    NASDAQ  2904.08  
 and more..
Search
sponsered by
  
  



Processing
Collecting necessary data for SLXP and PRGO...
    
  Salix Pharmaceuticals Ltd.  and    Perrigo Company
        
    
Diversification
Very good diversification
Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and Perrigo Company in the same portfolio (assuming nothing else is changed)
    
    
Correlation Coefficient
-0.3
 Parameters
Time Period1 Month [change]
DirectionNegative SLXP Moved Down vs PRGO
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns
    
    

       

Salix Pharmaceuticals Ltd.

    
    
48.43
  
Salix Quote
Intraday
 
Salix Intraday Quote
One Month
 0.00   No Change   0.00%  
SLXP Macroaxis: United States NASDAQ
Salix Pharmaceuticals Ltd.
P/E37.25LowNot Applicable
P/B Ratio5.96Market Cap2.864B
SectorHealthcareLast Close48.43
Short Ratio7.80Last Traded2/7/2012
Year High50.28Change (%)Not Applicable
EBITDA142.7MYear Low25.64
Book Value8.127EPS1.30
PEG Ratio0.94Employees390
Target Price54.27Current EPS1.30
This Year EPS2.53Next Year EPS2.78
Current PE37.25This Year PE19.14
Next Year PE17.42DividendNot Applicable
  

Perrigo Company

    
    
95.26
  
Perrigo Quote
Intraday
 
Perrigo Intraday Quote
One Month
 0.00   No Change   0.00%  
PRGO Macroaxis: United States NASDAQ
Perrigo Company
P/E26.63LowNot Applicable
P/B Ratio5.75Market Cap8.877B
SectorHealthcareLast Close95.26
Short Ratio2.20Last Traded2/7/2012
Year High104.70Change (%)Not Applicable
EBITDA625.6MYear Low70.94
Book Value16.553EPS3.577
PEG Ratio1.46Employees8,660
Target Price105.46Current EPS3.577
This Year EPS4.74Next Year EPS5.34
Current PE26.63This Year PE20.10
Next Year PE17.84Dividend0.29
Dividend Yield0.30Dividend DateMar 20